Bayer Must Face FCA Claims Over Off-Label Trasylol Marketing
A New Jersey federal judge declined Monday to reconsider his order allowing two False Claims Act claims in a whistleblower's long-running suit against Bayer Corp. for allegedly pushing off-label uses of...To view the full article, register now.
Already a subscriber? Click here to view full article